Invention Grant
US07955590B2 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
有权
Fc融合蛋白,用于增强蛋白质和肽抗原的免疫原性
- Patent Title: Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
- Patent Title (中): Fc融合蛋白,用于增强蛋白质和肽抗原的免疫原性
-
Application No.: US11089426Application Date: 2005-03-24
-
Publication No.: US07955590B2Publication Date: 2011-06-07
- Inventor: Stephen D. Gillies , Kin-Ming Lo , John S. Wesolowski, Jr.
- Applicant: Stephen D. Gillies , Kin-Ming Lo , John S. Wesolowski, Jr.
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Goodwin Procter LLP
- Main IPC: A61K39/395
- IPC: A61K39/395

Abstract:
Disclosed herein are methods and compositions for enhancing the immunogenicity of a preselected protein or peptide antigen in a mammal. Immunogenicity is enhanced by fusing the preselected antigen to an immunoglobulin heavy chain constant region to produce an Fc-antigen fusion protein. The Fc-antigen fusion proteins bind Fc receptors on the surface of antigen presenting cells, thereby targeting the antigen to the antigen presenting cells in the mammal. In addition, disclosed is a family of adjuvants, for example, an Fc-adjuvant fusion protein, for use in combination with the Fc-antigen fusion proteins to enhance or modulate a particular immune response against the preselected antigen.
Public/Granted literature
- US20050261229A1 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens Public/Granted day:2005-11-24
Information query